skip to Main Content

IBT’s reagent line covers a range of viruses. Product types include antisera, and purified polyclonal antibodies against these viruses.

Specific targets covered include Crimean-Congo Hemorrhagic Fever Virus (CCHFV); Japanese Encephalitis Virus (JEV); Junin and Lassa Viruses; Rift Valley Fever Virus (RVFV); Vaccinia; etc.

If you have any questions or would like to inquire about discounts for bulk purchases, please contact us.

    NotesProduct NameTargetCat #SizeDatasheetPriceBuy
    NewNipah virus Attachment G proteinNipah virus0580-001100 ug$460.00
    Rabbit anti-CCHFV Gc pAbCrimean-Congo Hemorrhagic Fever Virus04-0012100ug$450.00
    Rabbit anti-CCHFV N protein pAbCrimean-Congo Hemorrhagic Fever Virus04-0011100 ug$450.00
    Rabbit anti-Japanese Encephalitis (JEV) antiserumJapanese Encephalitis Virus01-0007250 uL$354.00
    Rabbit anti-Junin antiserumJunin Virus01-0006250 uL$396.00
    Rabbit anti-Junin pAbJunin Virus04-0006500 ug$240.00
    Rabbit anti-LASV GP pAbLassa Virus0307-001100 ug$420.00
    Rabbit anti-LASV Z pAbLassa Virus0307-002100 ug$420.00
    Out of StockRabbit anti-Rift Valley Fever (RVFV) antiserumRabbit anti-Rift Valley Fever (RVFV) antiserum01-0001250 uL$396.00
    Out of StockRabbit anti-Rift Valley Fever (RVFV) pAbRift Valley Fever Virus04-0001500 ug$240.00
    Rabbit anti-Vaccinia antiserumVaccinia Virus01-0003250 uL$396.00
    Rabbit anti-Zika GP pAbZika virus0308-001100 ug$425.00
    Rabbit anti-Zika NS1 pAbZika Virus0308-002100 ug$425.00
    Recombinant Lassa Virus Z ProteinLassa Virus0508-001100 ug$435.00
    Recombinant Zika Ev2-dimer (S2)Zika Virus0556-002100 ug$435.00
    Recombinant Zika Ev2-monomer (S2)Zika Virus0556-001100 ug$435.00
    Recombinant Zika Ns2B-Ns3 (S2)Zika Virus0555-001100 ug$435.00
    West Nile Virus-NS1 (S2)West Nile Viurs0557-001100 ug$435.00
    Back To Top
    Fig. 1 Survival after challenge with INFV H1N1 A/Pert/261/2009 (Tamiflu-resistant strain). Inoculum 1xLD90=1.0E+05 PFU/mouse
    Survival after challenge with INFV H1N1 A/Pert/261/2009 (Tamiflu-resistant strain) 1.0E+05 PFU/mouse
    Survival and weight change in BALB/c mice challenged with INFV A/ Texas/36/91 (H1N1) and treated with antiviral Osletamivir Phosphate (Tamiflu)
    Lung viral load and Survival (30 % weight loss cut-off) in BALB/c mice challenged with INFV H3N2 A/HK/1/68.

    Alpha (UK) – B. 1.1.7 / 501Y.V1

    amino acid mutations: del69–70 HV, del144 Y, N501Y, A570D, D614G, P681H, T761I, S982A, D1118H

    Beta (South Africa) – B.1.351

    amino acid mutations: K417N, E484K, N501Y, D614G, A701V

    Gamma (Brazil) – P.1

    amino acid mutations: L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I

    Epsilon (Ca, USA) B.1.427

    amino acid mutations: L452R, D614G

    SARS-CoV-2 Parental Strain Wild Type (Wuhan)
    SARS-CoV-2 D614G Variant

    amino acid mutations: D614G

    Epsilon (Ca, USA) B.1.429

    amino acid mutations: S13I, W152C, L452R, D614G

    SARS-CoV-2 Delta Variant

    amino acid mutations: L452R, E484Q